Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
Recruiting · NCT04945148 · Registry updated 2025-11-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2025-11-21 | NCT04945148 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hopital Foch | 23 |
| National Cancer Institute, France | 61 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Foch Hospital | Suresnes | France | 1 |
| Hôpital Neurologique Pierre Wertheimer | Bron | France | 1 |
| Istituto Nazionale Carlo Besta | Milan | Italy | 1 |
| Pitié Salpêtrière Hospital | Paris | France | 2 |
| Saint Louis Hospital | Paris | France | 1 |
| Spidali Riuniti Di Livorno | Livorno | Italy | 1 |
| Timone Hospital | Marseille | France | 1 |